The Genome as Selection Substrate (Jun 4 2026) — is mass DNA harvesting the operational layer of the eugenic carve-out?
In plain terms
CROWD: '23andMe was just a data breach / embryo screening is just disease prevention.' ENGINE (research-verified): the 23andMe $305 million sale of ~15M genomes to TTAM (over the ombudsman's consent warnings; Judge Walsh 6/27/25), the UK Biobank 500k→Alibaba breach (Apr 2026),…
Analysis
CROWD: '23andMe was just a data breach / embryo screening is just disease prevention.' ENGINE (research-verified): the 23andMe $305 million sale of ~15M genomes to TTAM (over the ombudsman's consent warnings; Judge Walsh 6/27/25), the UK Biobank 500k→Alibaba breach (Apr 2026), BGI's global harvest, and Heliospect's UK-Biobank-derived embryo IQ-ranking ($50k, ~100 embryos) together make the Selection Carve-Out OPERATIONAL — the genome is the substrate that makes lineage selection actionable. HELD as emergent (commercial+state competition; bankruptcy chaos + BIOSECURE state-vs-state fracture keep Claim A dead). Nordic/Grey = engineered-human synthesis-candidates at CELL stage only (Dsup/MSTN in human cells+mice; no organism). All facts independently verified; the apex-program reading stays held, name no holder.